Experiences with abiraterone in the treatment of prostate cancer

Simple item page
dc.contributor.authorRichter Igorcs
dc.contributor.authorDvořák Josefcs
dc.date.accessioned2022-01-29T18:14:14Z
dc.date.available09-38-2021en
dc.date.available2022-01-29T18:14:14Z
dc.date.issued2020cs
dc.format.extent2cs
dc.identifier.issn1801-1209cs
dc.identifier.urihttps://dspace.tul.cz/handle/15240/161633
dc.language.isoczecs
dc.publisher.cityPrahacs
dc.relation.ispartofFarmakoterapieen
dc.subjectProstate cancercs
dc.subjectmetastasescs
dc.subjectchemotherapycs
dc.subjecthormonal treatmentcs
dc.subjecttargeted treatmentcs
dc.subjecttreatment toxicitycs
dc.titleExperiences with abiraterone in the treatment of prostate canceren
dc.titleZkušenosti s léčbou abirateronem u pacienta s karcinomem prostatycs
local.citation.epage132-133cs
local.citation.spage132-133cs
local.identifier.publikace8330
Files
Collections